Baseline clinical laboratory tests in our population.
CIN
BRAIN, CIN
Data are expressed as median (SIQR: semi-interquartile range).ALAT: alanine aminotransferase ASAT: aspartate aminotransferase, CK: creatine kinase levels, LDH: Lactate dehydrogenase, LDL: Low-density cholesterol, eGFR: estimated glomerular filtration rate;, hsCRP: high-sensitivity C-reactive protein; intervention, ProBNP: Pro Brain natriuretic peptideThe primary end-point of SCr-based CIN occurred in 11 patients (10%). There was no statistical difference in Scr-based CIN incidence between the AR group and the NR group (11.1% versus 8.9%, p = 0.7). The overall incidence of CyC-based CIN was higher than Scr-based CIN and it was calculated to be 31.8% (35/110) of the patients. This incidence was 37% in the NR group and 26.8% in the AR group without any statistical difference between the two groups (p = 0.24) (